US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Abdominal Aortic Aneurysms - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Abdominal Aortic Aneurysms, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Endothelial Dysfunction - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... therapeutic development for Endothelial Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ischemic Cerebral Stroke - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Ischemic Cerebral Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for Pseudomonas Aeruginosa Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Difficile Infections (Clostridium Difficile Associated Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease), complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Breast Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Rheumatoid Arthritis - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Anthrax Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Bacterial (Pyogenic) Meningitis Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Bacterial (Pyogenic) Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Colorectal Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Inflammatory Bowel Disease - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Gastric Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Gastric Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Acute Lung Injury - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Acute Lung Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Contraception - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... Contraception, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... Aureus Infection (VRSA)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vancomycin Resistant Staphylococcus Aureus Infection (VRSA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... Acute Respiratory Syndrome (SARS) Coronavirus Infection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
Chlamydia Infections - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic development for Chlamydia Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bacillus Anthracis Infections - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... information on the therapeutic development for Bacillus Anthracis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Idiopathic Juvenile Arthritis (Still's Disease) - Pipeline Review, H2 2014
11/18/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Juvenile Arthritis (Still's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Prostate Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Prostate Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
HIV Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Non-Hodgkin Lymphoma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Non-Hodgkin Lymphoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Multiple Sclerosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Multiple Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
1    3    5  6  7  8  9  10